Oxidative stress adaptation in aggressive prostate cancer may be counteracted by the reduction of glutathione reductase

FEBS Open Bio

Volumn 2, Issue , 2012, Pages 119-128

  Freitas, Mariana ^a,b   Baldeiras, Inês ^b,c   Proença, Teresa ^b,c   Alves, Vera ^a   Mota Pinto, Anabela ^a   Sarmento Ribeiro, Ana ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Cell line; Glutathione (GSH); Glutathione reductase (Gl Red); Oxidative stress (OS); Prostate cancer; Reactive oxygen species (ROS)

Indexed keywords

GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HYDROGEN PEROXIDE; MALEIC ACID DIETHYL ESTER; REACTIVE OXYGEN METABOLITE;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 84862228730     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2012.05.001     Document Type: Article

References (60)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., Thun M.J. Cancer statistics 2008. CA Cancer J. Clin. 2008, 587:71-96.
2. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics 2010. CA Cancer J. Clin. 2010, 60(5):277-300.
3. Jung K., Seidel B., Rudolph B., Lein M., Cronauer M.V., Henke W., Hampel G., Schnorr D., Loening S.A. Antioxidant enzymes in malignant prostate cell lines and in primary cultured prostatic cells. Free Radic. Biol. Med. 1997, 23:127-133.
4. Baker A.M., Oberley L.W., Cohen M.B. Expression of antioxidant enzymes in human prostatic adenocarcinomas. Prostate 1997, 32:229-233.
5. Oberley T.D., Zhong W., Szweda L.I., Oberley L.W. Localization of antioxidant enzymes and oxidative damage products in normal and malignant prostate epithelium. Prostate 2000, 44:144-155.
6. Bostwick D.G., Alexander E.E., Singh R., Shan A., Qian J., Santella R.M., Oberley L.W., Yan T., Zhong W., Jiang X., Oberley T.D. Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer. Cancer 2000, 89:123-134.
7. Sikka S.C. Role of oxidative stress response elements and antioxidants in prostate cancer pathobiology and chemoprevention-a mechanistic approach. Curr. Med. Chem. 2003, 10(24):2679-2692.
8. Trzeciak A.R., Nyaga S.G., Jaruga P., Lohani A., Dizdaroglu M., Evans M.K. Cellular repair of oxidatively induced DNA base lesions is defective in prostate cancer cell lines PC-3 and DU-145. Carcinogenesis 2004, 25:1359-1370.
9. Lim H.W., Hong S., Jin W., Lim S., Kim S.J., Kang H.J., Park E.H., Ahn K., Lim C.J. Up-regulation of defense enzymes is responsible for low reactive oxygen species in malignant prostate cancer cells. Exp. Mol. Med. 2005, 37(5):497-506.
10. Venkataraman S., Jiang X., Weydert C., Zhang Y., Zhang H.J., Goswami P.C., Ritchie J.M., Oberley L.W., Buettner G.R. Manganese superoxide dismutase overexpression inhibits the growth of androgen-independent prostate cancer cells. Oncogene 2005, 24:77-89.
11. Aydin A., Arsova-Sarafinovska Z., Sayal A., Eken A., Erdem O., Erten K., Ozgök Y., Dimovski A. Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia. Clin. Biochem. 2006, 39:176-179.
12. Yossepowitch O., Pinchuk I., Gur U., Neumann A., Lichtenberg D., Baniel J. Advanced but not localized prostate cancer is associated with increased oxidative stress. J. Urol. 2007, 178(4):1238-1244.
13. Sies H. Oxidative stress: introductory remarks. Oxidative Stress 1985, 1-8. Academic Press, London. H. Sies (Ed.).
14. Sies H. Oxidative stress: oxidants and antioxidants. Exp. Physiol. 1997, 82(2):291-295.
15. Shimizu H., Ross R.K., Bernstein L., Yatani R., Henderson B.E., Mack T.M. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br. J. Cancer 1991, 63:963-966.
16. Whittemore A.S., Kolonel L.N., Wu A.H., John E.M., Gallagher R.P., Howe G.R., Burch J.D., Hankin J., Dreon D.M., West D.W., Teh C.-Z., Paffenbarger R.S. Prostate cancer in relation to diet physical activity and body size in blacks whites and Asians in the United States and Canada. J. Natl. Cancer Inst. 1995, 87:652-661.
17. Gronberg H. Prostate cancer epidemiology. Lancet 2003, 361:859-864.
18. Jian L., Xie P., Lee A.H., Binns C.W. Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int. J. Cancer 2004, 108:130-135.
19. Nelson W.G., DeWeese T.L., DeMarzo A.M. The diet inflammation and the development of prostate cancer. Cancer Metastasis Rev. 2002, 21:3-16.
20. De Marzo A.M., Platz E.A., Sutcliffe S., Xu J., Grönberg H., Drake C.G., Nakai Y., Isaacs W.B., Nelson W.G. Inflammation in prostate carcinogenesis. Nat. Rev. Cancer 2007, 7:256-269.
21. Kwabi-Addo B., Chung W., Shen L., Ittmann M., Wheeler T., Jelinek J., Issa J.-P. Age-related DNA methylation changes in normal human prostate tissues. Clin. Cancer Res. 2007, 13:3796-3802.
22. Halliwell B., Gutteridge J.M.C. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 1990, 186:1-85.
23. Aruoma O.I. Free radicals oxidants and antioxidants: trend towards the year 2000 and beyond. Molecular Biology of Free Radicals in Human Diseases 1998, 1-28. OICA International, St. Lucia, London. O.I. Aruoma, B. Halliwell (Eds.).
24. 2 for platelet-derived growth factor signal transduction. Science 1995, 270:296-299.
25. Murrell G.A., Francis M.J., Bromley L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem. J. 1990, 265(3):659-665.
26. Burdon R.H. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic. Biol. Med. 1995, 18:775-794.
27. del Bello B., Paolicchi A., Comporti M., Pompella A., Maellaro E. Hydrogen peroxide produced during gamma-glutamyl transpeptidase activity is involved in prevention of apoptosis and maintenance of proliferation in U937 cells. FASEB J. 1999, 13(1):69-79.
28. Sauer H., Wartenberg M., Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell. Physiol. Biochem. 2001, 11:173-186.
29. Courtney G., Havens A.H., Naohisa Y., Steven F.D. Regulation of late G1/S phase transition and APCCdh1 by reactive oxygen species. Mol. Cell. Biol. 2006, 26(12):4701-4711.
30. Boonstra J., Post J.A. Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene 2004, 337:1-13.
31. Chandel N.S., Maltepe E., Goldwasser E., Mathieu C.E., Simon M.C., Schumacker P.T. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl. Acad. Sci. USA 1998, 95:11715-11720.
32. Allen R.G., Balin A.K. Oxidative influence on development and differentiation: an overview of a free radical theory of development. Free Radic. Biol. Med. 1989, 6(6):631-661.
33. Martindale J.L., Holbrook N.J. Cellular response to oxidative stress: signalling for suicide and survival. J. Cell. Physiol. 2002, 192:1-15.
34. Suzuki Y., Kondo Y., Himeno S., Nemoto K., Akimoto M., Amura N. Role of antioxidant systems in human androgen-independent prostate cancer cells. Prostate 2000, 43:144-149.
35. Shackelford R.E., Kaufmann W.K., Paules R.S. Oxidative stress and cell cycle checkpoint function. Free Radic. Biol. Med. 2000, 28:1387-1404.
36. Guyton K.Z., Kensler T.W. Oxidative mechanisms in carcinogenesis. Br. Med. Bull. 1993, 49(3):523-544.
37. Haimovitz-Friedman A. Radiation-induced signal transduction and stress response. Radiat. Res. 1998, 150:102-108.
38. Freitas M., Alves V., Sarmento-Ribeiro A.B., Mota-Pinto A. Combined effect of sodium selenite and docetaxel on PC3 metastatic prostate cancer cell line. Biochem. Biophys. Res. Commun. 2011, 408:713-719.
39. Weijerman P.C., König J.J., Wong S.T., Niesters H.G., Peehl D.M. Lipofection-mediated immortalization of human prostatic epithelial cells of normal and malignant origin using human papillomavirus type 18 DNA. Cancer Res. 1994, 54(21):5579-5583.
40. Kaighn M.E., Narayan K.S., Ohnuki Y., Lechner J.F., Jones L.W. Establishment and characterization of a human prostatic carcinoma cell line (PC3). Invest. Urol. 1979, 17(1):16-23.
41. Bello D., Webber M.M., Kleinman H.K., Wartinger D.D., Rhim J.S. Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis 1997, 18:1215-1223.
42. Alley M.C., Scudiero D.A., Monks A., Hursey M.L., Czerwinski M.J., Fine D.L., Abbot B.J., Mayo J.G., Shoemaker R.H., Boyd M.R. Feasibility of drug screening with panels of human tumour cell lines using a microculture tetrazolium assay. Cancer Res. 1998, 48(3):589-601.
43. Boldyrev A.A. Discrimination between apoptosis and necrosis of neurons under oxidative stress. Biochemistry (Mosc.) 2000, 65:834-842.
44. Cossarizza A., Baccarini-Contri M., Kalashnikova G., Franceschi C. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using J-aggregate forming lipophilic cation 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem. Biophys. Res. Commun. 1993, 197:40-45.
45. Rothe G., Valet G. Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2,7 dichlorofluorescein. J. Leukoc. Biol. 1990, 47(5):440-448.
46. Lee H.C., Yin P.H., Lu C.Y., Chi C.W., Wei Y.H. Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cells. Biochem. J. 2000, 348:425-432.
47. Gao F., Yi J., Yuan J.Q., Shi G.Y., Tang X.M. The cell cycle related apoptotic susceptibility to arsenic trioxide is associated with the level of reactive oxygen species. Cell Res. 2004, 14:81-85.
48. Tsao S.-M., Yin M.-C., Liu W.-H. Oxidant stress and B vitamins status in patients with non-small cell lung cancer. Nutr. Cancer 2007, 59(1):8-13.
49. Plagia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 1967, 70:158-169.
50. Goldberg, D.M. and Spooner, R.J. (1983) Glutathione reductase in: Methods in Enzymatic Analysis (Bergmeryer, U.H., Ed.), pp. 258-265, Verlag Chemie Weinheim Academic Press, New York.
51. Kullich W., Fagerer N., Schwann H. Effect of the NSAID nimesulide on the radical scavenger glutathione-S-transferase in patients with osteoarthritis of the knee. Curr. Med. Res. Opin. 2007, 23(8):1981-1986.
52. Knight J.A., Pieper R.K., McClellan L. Specificity of the thiobarbituric acid reaction: its use in studies of lipid peroxidation. Clin. Chem. 1998, 34(12):2433-2438.
53. Draper H.H., Hadley M. Malondialdehyde determination as an index of lipid peroxidation. Methods Enzymol. 1990, 186:421-431.
54. Miller J.K., Brzezinska-Slebodzinska E., Madsen F.C. Oxidative stress antioxidants and animal function. J. Dairy Sci. 1993, 76:2812-2823.
55. Kumar B., Koul S., Khandrinka L., Meacham R.B., Koul H.K. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res. 2008, 68(6):1777-1785.
56. Mishina T., Watanabe H., Araki H., Nakao M. Epidemiological study of prostatic cancer by matched-pair analysis. Prostate 1985, 6:423-446.
57. Loeb K.R., Loeb L.A. Significance of multiple mutations in cancer. Carcinogenesis 2000, 21(3):379-385.
58. Khandrika L., Kumar B., Koul S., Maroni P., Koul H.K. Oxidative stress in prostate cancer. Cancer Lett. 2009, 282(2):125-136.
59. Coffey R.N.T., Watson R.W.G., Hegarty N.J., O'Neill A., Gibbons N., Brady H.R., Fitzpatrick J.M. Thiol mediated apoptosis in prostate carcinoma cells. Cancer 2000, 88(9):2092-2104.
60. Coffey R.N.T., Watson R.W.G., Hegarty P.K., Watson C.L., Woloham L., Brady H.R., O'Keane C., Fitzpatrick J.M. Priming prostate cancer cells for increased apoptosis is associated with up-regulation of the caspases. Cancer 2001, 92(9):2297-2308.